Product Details
Product Details
Product Specification
| Antigen | Human E-selectin/CD62E |
| Immunogen | Recombinant Protein |
| Antibody Type | Recombinant mAb |
| Reactivity | Hu |
| Cross Reactivity | Mk |
| Purification | Protein A |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8°C as supplied. |
Kit
| Precision | Intra-assay: 4.0%; Inter-assay: 4.5% |
| Sample type | Serum; EDTA Plasma, Heparin Plasma, Citrate Plasma; Cell Culture Supernatant |
| Assay type | Sandwich (quantitative) |
| Sensitivity | 6.12 pg/mL |
| Range | 15.63 pg/mL – 1000 pg/mL |
| Recovery | Serum: 94% EDTA Plasma: 97% Citrate plasma: 98% Heparin Plasma: 100% Cell Culture Supernatant: 100% |
| Assay time | 60 minutes |
| Species reactivity | Hu |
| CROSS REACTIVITY | Mk |
Background
E-selectin (also known as CD62E, ELAM-1, or SELE) is a type I transmembrane glycoprotein belonging to the selectin family of cell adhesion molecules. It is exclusively expressed on activated vascular endothelial cells in response to inflammatory cytokines such as IL-1β and TNF-α. Unlike P-selectin, which is pre-stored in Weibel-Palade bodies, E-selectin requires de novo gene transcription and protein synthesis. It is a cell adhesion glycoprotein exclusively expressed on activated vascular endothelial cells during inflammation, mediating the initial rolling and tethering of leukocytes via calcium-dependent recognition of sialyl Lewis X/Lewis A glycans. Beyond its central role in leukocyte trafficking, E-selectin is implicated in tumor metastasis, angiogenesis, and immune regulation. Soluble E-selectin serves as a clinical biomarker for endothelial activation in cardiovascular disease, sepsis, and autoimmune disorders. Consequently, E-selectin proteins are indispensable tools for both fundamental mechanistic studies and the development of diagnostic or therapeutic strategies targeting pathological inflammation and cancer spread.
